G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L

Tao Zhang(Chinese Academy of Sciences), Kangyun Dong(Chinese Academy of Sciences), Wei Liang(Chinese Academy of Sciences), Daichao Xu(Chinese Academy of Sciences), Hongguang Xia(Harvard University), Jiefei Geng(Harvard University), Ayaz Najafov(Harvard University), Min Liu(Chinese Academy of Sciences), Yanxia Li(Chinese Academy of Sciences), Xiaoran Han(Fudan University), Juan Xiao(Chinese Academy of Sciences), Zhenzhen Jin(Huazhong University of Science and Technology), Ting Peng(Huazhong University of Science and Technology), Yang Gao(Huazhong University of Science and Technology), Yu Cai(Chinese Academy of Sciences), Chunting Qi(Chinese Academy of Sciences), Qing Zhang(Chinese Academy of Sciences), Anyang Sun(Chinese Academy of Sciences), Marta M. Lipinski(Harvard University), Hong Zhu(Harvard University), Yue Xiong(University of North Carolina at Chapel Hill), Pier Paolo Pandolfi(Beth Israel Deaconess Medical Center), He Li(Huazhong University of Science and Technology), Qiang Yu(Chinese Academy of Sciences), Junying Yuan(Harvard University)
eLife
March 30, 2015
Cited by 95Open Access
Full Text

Abstract

Autophagy is an important intracellular catabolic mechanism involved in the removal of misfolded proteins. Atg14L, the mammalian ortholog of Atg14 in yeast and a critical regulator of autophagy, mediates the production PtdIns3P to initiate the formation of autophagosomes. However, it is not clear how Atg14L is regulated. In this study, we demonstrate that ubiquitination and degradation of Atg14L is controlled by ZBTB16-Cullin3-Roc1 E3 ubiquitin ligase complex. Furthermore, we show that a wide range of G-protein-coupled receptor (GPCR) ligands and agonists regulate the levels of Atg14L through ZBTB16. In addition, we show that the activation of autophagy by pharmacological inhibition of GPCR reduces the accumulation of misfolded proteins and protects against behavior dysfunction in a mouse model of Huntington's disease. Our study demonstrates a common molecular mechanism by which the activation of GPCRs leads to the suppression of autophagy and a pharmacological strategy to activate autophagy in the CNS for the treatment of neurodegenerative diseases.


Related Papers

No related papers found

Powered by citation graph analysis